第一单位：
Hospices Civils de Lyon, Lyon, France.;CRCL, UMR INSERM 1052/CNRS 5286/University of Lyon-France, Lyon, France.
作者：
Charles,Dumontet [1]
;
Delphine,Demangel [2]
;
Perrine,Galia [2]
;
Lionel,Karlin [2]
;
Laurent,Roche [2]
;
Mathieu,Fauvernier [2]
;
Camille,Golfier [2]
;
Marie-Charlotte,Laude [2]
;
Xavier,Leleu [3]
;
Philippe,Rodon [4]
;
Murielle,Roussel [5]
;
Isabelle,Azaïs [3]
;
Chantal,Doyen [6]
;
Borhane,Slama [7]
;
Salomon,Manier [8]
;
Olivier,Decaux [9]
;
Maroulio,Pertesi [10]
;
Marie,Beaumont [11]
;
Denis,Caillot [12]
;
Eileen M,Boyle [13]
;
Manuel,Cliquennois [14]
;
Pascale,Cony-Makhoul [15]
;
Anne-Violaine,Doncker [16]
;
Véronique,Dorvaux [17]
;
Marie Odile,Petillon [18]
;
Jean,Fontan [19]
;
Bénédicte,Hivert [14]
;
Isabelle,Leduc [20]
;
Cécile,Leyronnas [21]
;
Margaret,Macro [22]
;
Michel,Maigre [23]
;
Clara,Mariette [24]
;
Philippe,Mineur [25]
;
Sophie,Rigaudeau [26]
;
Bruno,Royer [27]
;
Laure,Vincent [28]
;
James,Mckay [29]
;
Emeline,Perrial [30]
;
Laurent,Garderet [31]
作者单位：
Hospices Civils de Lyon, Lyon, France.;CRCL, UMR INSERM 1052/CNRS 5286/University of Lyon-France, Lyon, France.
[1]
Hospices Civils de Lyon, Lyon, France.
[2]
Hematology Department, CHU Poitiers, Poitiers, France.
[3]
Hematology Department, CH Périgueux, Périgueux, France.
[4]
IUC-Oncopôle, Toulouse, France.
[5]
UCL Mont-Godinne, Louvain, Belgium.
[6]
Clinical Hematology Department, CH Avignon, Avignon, France.
[7]
Hematology Department, CHRU, Lille, France.
[8]
Hematology Department, CHU Rennes, Inserm UMR1236, Rennes, France.
[9]
Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France.;Department of Laboratory Medicine, Hematology and Transfusion Medicine, Lund, Sweden.
[10]
Hematology Department, CHU Dunkerque, Dunkerque, France.
[11]
Clinical Hematology Department, Hôpital F. Mitterrand, CHU Dijon, Dijon, France.
[12]
Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA.
[13]
Hospitals Organization of Catholic Institute, Lille, France.
[14]
CH Annecy Genevois, Pringy, France.
[15]
Private Hospital Sévigné, Cesson-Sévigné, France.
[16]
Clinical Hematology Department, CHR Metz-Thionville, Metz-Thionville, France.
[17]
Intergroupe Francophone du Myélome, France.
[18]
Hematology Department, CHU Besançon, Besançon, France.
[19]
Hematology Department, CH d'Abbeville, Abbeville, France.
[20]
Daniel Hollard Institute-GHM-Grenoble, Grenoble, France.
[21]
Hematology Department, CHU Caen, Caen, France.
[22]
Internal Medicine Department, CH Chartres, Chartres, France.
[23]
Hematology Department, CHU Grenoble, Grenoble, France.
[24]
Clinical Hematology Department, Grand Hôpital de Charleroi, Charleroi, Belgium.
[25]
Hematology Department, CH Versailles, Versailles, France.
[26]
Clinical Hematology and Cell Therapy Department, Amiens, France.
[27]
Clinical Hematology Department, CHU Montpellier, France.
[28]
Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France.
[29]
CRCL, UMR INSERM 1052/CNRS 5286/University of Lyon-France, Lyon, France.
[30]
HU PITIE SALPETRIERE APHP, Paris, France.;Centre de Recherche Saint-Antoine-Team Hematopoietic and Leukemic Development, Sorbonne Université-INSERM, UMR_S 938, Paris, France.
[31]
DOI
10.1002/ajh.26785
PMID
36588407
发布时间
2025-05-30
换一批
